LOS ANGELES, CA -- (Marketwired) -- 06/24/13 -- MMRGlobal, Inc. (OTCQB: MMRF) ("MMR") today announced that MMRGlobal CEO Robert H. Lorsch concluded a six day East Coast trip focused on sales and licensing of the Company's patented health information technology products and services on the heels of an article discussing how legislation and Stage 2 Meaningful Use is kicking PHR usage into high gear and the value of health information technology patents. The article, written by Waco Hoover, CEO of the Institute for Health Technology Transformation (iHT2), entitled "Patient Portals Get Front and Center," highlights the growth of the PHR industry and confirms that "patient portals have gained significant attention from healthcare providers as Stage 2 Meaningful Use requires eligible professionals ensure at least 5% of patients view, download or transmit their electronic health records."
The Company began its trip in Washington, DC where CEO Lorsch and Ted Ward at Liner Grode Stein Yankelevitz Sunshine Regenstreif & Taylor LLP, patent counsel for MMR, attended meetings with Congressional representatives regarding the need to create programs and initiatives that could drive additional healthcare stimulus dollars to small business enterprises, including small hospitals and product and service vendors. While in Washington, Lorsch and Ward were also guests at the Brazilian Embassy as part of MMR's efforts to leverage its intellectual property through global development initiatives in Qatar and Brazil. The Company already owns anti-CD20 antibody biotech patents in Brazil. In New York, MMR met with potential licensees, investment bankers, and competitors representing the largest providers of PHRs selling through employers, insurers and payers, and to consumers, similar to MMR.
The Institute's article, located at http://ihealthtran.com/wordpress/2013/06/patient-portals-get-front-and-center/, also cites that "a KLAS survey of 104 providers found that 57% already have a patient portal in place with the largest vendors including Cerner, Epic, Intuit Health, Jardogs, MEDSEEK, NextGen, and RelayHealth. With the growing demand for patient portals there is increased concern among vendors about their intellectual property and potential infringement from competitors. The most recent patent announcement came from WebMD and MyMedical Records (MMR). The two organizations have entered into an agreement attempting to resolve potential infringement on MMR's PHR and patient portal patent portfolio. The same announcement also mentioned that MMR initiated service of its patent infringement complaint filed against Jardogs LLC, one of the firms researched in the KLAS study. It's yet to be seen how the MMR IP negotiations will play out but other tech giants like McKesson, Google and Apple have been involved in patent suits resulting in settlements in the 100s of millions of dollars. With the health IT industry continuing its accelerated growth, patent infringement among vendors will become an increasingly important area of focus."
Most Popular Stories
- 5 Potential Snags to the Bipartisan Budget Deal
- Phil Pustejovsky's Relief Real Estate Offers Seminars in Daytona Beach
- Sonoma Growers Win Emerald Cup Cannabis Competition
- Rubio Offers Endorsements, Cash to 2014 GOP Candidates
- Legal Dope in Uruguay Breaks International Law, Says Buzzkill U.N.
- GM Plant Tackles Tough Waste Challenge
- Cantor Fitzgerald Settles Suit
- Pope Removes U.S. Archbishop from Powerful Post
- 'New Rich' May Be Barrier to Bridging Income Gap
- Researchers Question Effectiveness of Vitamins